Clasificar por
Keyphrases
Colombians
98%
Clopidogrel
87%
Pharmacological Analysis
70%
Next-generation Sequencing
66%
Colombian Patients
64%
Adverse Drug Reaction
59%
Polymorphism
55%
Acute Coronary Syndrome
47%
Molecular Variants
43%
Allele Frequency
37%
CYP2C19
35%
Platelet Reactivity
35%
Inter-individual Variability
34%
Mayors
33%
Pharmacogenetics
32%
CYP2C9
30%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
29%
Non-genetic Factors
29%
Pharmacogenomics
28%
Population Genetics
27%
COVID-19
25%
High On-treatment Platelet Reactivity
25%
Adverse Reactions
25%
Warfarin
25%
Warfarin Dose
25%
Colorectal Cancer
24%
Genetic Approach
23%
Prolonged Neuromuscular Blockade
23%
Phenytoin
23%
Pharmacogenetic Study
23%
New Risks
23%
Dosing Algorithm
23%
Warfarin Pharmacogenetics
23%
Antiplatelet Drugs
21%
Genetic Profile
21%
Genetic Risk
21%
Colombia
21%
Clopidogrel Response
20%
Personalized Medicine
17%
Anesthesia
17%
Pathogenic Variants
17%
Genetic Factors
17%
Coding Region
16%
Molecular Variation
15%
Warfarin Maintenance Dose
15%
Latin American
15%
Whole Exome Sequencing
14%
Rare Variants
14%
Closure Time
14%
Single nucleotide Polymorphism
14%
Patients with Epilepsy
13%
Pharmacogenetic Variants
13%
TFL1
13%
Regression Equation
13%
Translational Medicine
13%
CYP2C9 Polymorphism
13%
Pharmacogenes
13%
Latin American Populations
13%
Genotype Frequency
12%
CYP2C19 Polymorphism
12%
Therapeutic Response
12%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
12%
Functional Analysis
11%
Breast Cancer
11%
Colorectal Cancer Prevention
11%
Gene Variation
11%
US Latinos
11%
ADME Genes
11%
Paraoxonase 1 (PON1)
11%
Q192R Polymorphism
11%
Clopidogrel Therapy
11%
Long QT Syndrome
11%
QT Prolongation
11%
Patient Panel
11%
Panel Size
11%
Moderate-risk Genes
11%
Anticoagulated Patients
11%
Hereditary Breast Cancer Risk
11%
Dosage Prediction
11%
Private Medical Institution
11%
Butyrylcholinesterase (BChE)
11%
Succinylcholine
11%
Germline Alterations
11%
Microsatellite Instability-high (MSI-H)
11%
Drug Use
11%
Future Initiative
11%
Total Variability
11%
Report Analysis
11%
Epitope
11%
Molecular Mechanism
11%
Rhabdomyolysis
11%
Rosuvastatin
11%
Exome Sequencing
11%
Coronary Artery Disease
11%
New mutation
11%
Immunotherapeutics
11%
Pacientes
11%
Promoter Variants
11%
HLA-DRB1 Alleles
11%
Genome Analysis
11%
Biochemistry, Genetics and Molecular Biology
Pharmacogenetic Testing
100%
Clopidogrel
90%
Next Generation Sequencing
84%
Genetics
60%
Allele
53%
Genetic Determinism
50%
Pharmacogenetics
45%
Gene Frequency
39%
Platelet Reactivity
36%
CYP2C19
33%
Population Genetics
33%
Genomics
26%
Genetic Risk
26%
CYP2C9
26%
Reporter Gene
23%
Luciferase
23%
Exome Sequencing
23%
Genetic Approach
23%
Neuromuscular Blocking
23%
T Cell
23%
Transcription Factor
23%
Electrophoretic Mobility Shift Assay
23%
Missense
20%
Maintenance Drug Dose
17%
Promoter Region
17%
Metabolic Pathway
16%
Genetic Polymorphism
15%
Genetic Divergence
15%
Pharmacogenomics
14%
Single-Nucleotide Polymorphism
14%
Pharmacogenetic Variant
13%
BRCA1
11%
BRCA2
11%
Lymphoid Enhancer-Binding Factor 1
11%
Cancer Immunotherapy
11%
Coronavirinae
11%
Aryldialkylphosphatase
11%
Paraoxonase
11%
Drug Metabolism
11%
Germline
11%
Germ Cell
11%
VKORC1
11%
Cholinesterase
11%
K-Complex
11%
Suxamethonium Chloride
11%
Gene Expression
11%
Genetic Variation
11%
Tumor Escape
11%
Binding Site
11%
Case-Control Study
11%
Pharmacokinetic
11%
P2Y12
8%
Regulatory Region
8%
Dideoxynucleotide Sequencing
7%
CYP2C9*3
7%
SARS Coronavirus
6%
Gene Pool
6%
Digital Positive Youth Development
5%
Biotransformation
5%
Coding Region
5%
Pharmacodynamics
5%
Metabolite
5%
Thrombocyte Aggregation
5%
Adenosine Diphosphate
5%
Drug Response
5%
Rare Variant
5%
Wild Type
5%